Company Overview
Company Type: Public Company
Company Status: Operating Subsidiary
Website: www.xybion.com
Number of Employees: 138
Ticker: XYBN (TSXV)
Year Founded: -


Business Description
Xybion Digital Inc., a software-as-a-service company, provides software solutions for life sciences and health systems companies in the United States and internationally. Its software solutions include Pristima XD, an integrated digital laboratory execution system; Labwise XD, a laboratory operations software to manage GMP and non-GMP-compliant process flows; and digital pathology software solutions. The company also provides COVID-19 test management application; Savante, a data warehouse, analytics, and SEND management system; CQRM XD, a unified cloud based software for predictive compliance, quality, and risk management; Compliance Risk Predictor to predict compliance risks, mitigate, and eliminate; and Compliance Builder, a real-time compliance monitoring software. In addition, it offers Emidence XD, a total workforce health and safety solution; ECM XD, a cloud-based digital platform for managing enterprise content; CQRM XD Quality Management, an all-in-one quality management software and enterprise content management platform, as well as governance, risk, and compliance platform; and QMS OpenText, a quality and compliance management solution. Further, the company provides project management, computer system validation, and software development and testing services. It serves clients in life sciences, workplace health, safety and worker’s compensation, transportation, energy, financial services, enterprise solutions, healthcare and insurance, and government industries. The company is headquartered in Princeton, New Jersey. Xybion Digital Inc. is a subsidiary of Banerjee Group LLC.

Financial Information (Currency: CAD, in mm) 
Total Revenue
22.6
Market Capitalization
28.4
TEV/Total Revenue
1.1x
EBITDA
(2.5)
Total Enterprise Value
25.2
TEV/EBITDA
NM
EBIT
(2.7)
Cash & ST Invst.
4.6
P/Diluted EPS Before Extra
NM
Net Income
(2.1)
Total Debt
1.3
Price/Tang BV
4.3x
Capital Expenditure
0.0
Total Assets
19.2
Total Debt/EBITDA
NM
Currency in CAD in mm, LTM as of Dec-31-2022 TEV and Market Cap are calculated using a close price as of Sep-29-2023

Key Professionals
Name
Title
Banerjee, Pradip K.
Founder, CEO & Chairman of the Board
Biswas, Kamal 
President & COO
Porfano, Steven L.
CFO, Corporate Secretary & Executive VP
Abdallah, Mustafa 
Executive Director of Quality & Compliance Services
Friedman, Bob 
Chief Solution Architect
Krueger, Heidi 
Head of Quality Assurance
Rabenstein, Shawn 
Head of IT
Roy, Anu 
Chief Solutions Delivery Officer

Key Board Members
Name
Title
Banerjee, Pradip K.
Founder, CEO & Chairman of the Board
McCoach, John 
Independent Director
Bailey, Peter 
Independent Lead Director


Primary Industry Classification
Health Care Technology


Primary Office Location
105 College Street East | Princeton, NJ | 08540 | United States
Phone: 609 512 5790   Fax: 609 482 3823

Parent Company
Banerjee Group LLC

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 0.54
Market Cap (mm)
28.3
Open
 0.54
Shares Out. (mm)
52.4
Previous Close
 0.54
Float %
2.9%
Change on Day
0.05
Shares Sold Short (mm)
-
Change % on Day
10.2%
Dividend Yield %
0.0%
Day High/Low
 0.54/ 0.54
Diluted EPS Excl. Extra Items
(0.04)
52 wk High/Low
 3.40/ 0.37
P/Diluted EPS Before Extra
NM
Volume (mm)
0.0040
Avg 3M Dly Vlm (mm)
0.03
Beta 5Y
-


 
Delayed Quote** | Last Updated on Sep-29-2023 12:00 AM (GMT-5)


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
Gravitas One Capital Corp.
As of November 15, 2021, Gravitas One Capital Corp. was acquired by Xybion Corporation, in a reverse merger transaction. Gravitas One Capital Corp. is a capital pool company. The company focuses on the identification and evaluation of assets or businesses with a view to completing a qualifying transaction. The company was incorporated in 2020 and is based in Vancouver, Canada.

United States and Canada
Asset Management and Custody Banks
-
1.00
0.00
Vital Path, Inc. and Stelex-The Validation Group, Inc.
Vital Path, Inc. and Stelex-The Validation Group, Inc. represent the combined operation of Stelex-The Validation Group, Inc. and Vital Path, Inc. in their sale to Xybion Medical Systems Corporation. As of May 10, 2010, Vital Signs, Inc. and Stelex-The Validation Group, Inc. were acquired by Xybion Medical Systems Corporation. Stelex-The Validation Group, Inc., a consulting company, provides business solutions to life science/healthcare, transportation, distribution, manufacturing, and legal industries. Vital Path, Inc. develops content integration and migration, and business process management solutions. The companies are based in Bensalem, Pennsylvania.

United States and Canada
IT Consulting and Other Services
-
-
-
Amadeus International, Inc.
As of December 1, 2009, Amadeus International, Inc. was acquired by Xybion Medical Systems Corporation. Amadeus International, Inc. provides enterprise quality and compliance management software solutions. It offers a software solution for enterprise quality and compliance management (eQCM), a Web-based solution that enables organizations to comply with requirements stemming from ISO standards and manufacturing regulations, financial reporting and governance regulations, and various industry standards and risk-based regulations. The company’s product manages and controls compliance and quality by automating various processes, such as document management, corrective and preventive actions, non-conformances and defects, complaints management, audits, training, incident management, corporate governance, and various related quality and business processes. It serves life sciences, pharmaceutical and biotechnology, medical device, manufacturing, and financial services markets. Amadeus International, Inc. was founded in 1994 and is based in Quebec, Canada.

United States and Canada
Application Software
1.00
1.00
0.00
Stelex-The Validation Group, Inc.
Stelex-The Validation Group, Inc., a consulting company, provides business solutions to life science/healthcare, transportation, distribution, manufacturing, and legal industries. It offers PROMON that enables automatic data collection and work order generation based on configurable conditions out of the box; Complete Audit Trail that brings the history of various changes for a particular record; Batch Record Import/Export System, a solution for Maximo mass importing and exporting of content information from Microsoft Access; Quality Management System, an integrated solution to manage quality issues and initiatives; Process Management Framework; and ComplianceBuilder, a legacy system. The company provides business, regulatory, technology, and validation solutions. Stelex-The Validation Group, Inc. was formerly known as The Validation Group, Inc. and changed its name to Stelex-The Validation Group, Inc. in March 2002. The company was founded in 1986 and is based in Bensalem, Pennsylvania. As of May 10, 2010, Stelex-The Validation Group, Inc. operates as a subsidiary of Xybion Medical Systems Corporation.

United States and Canada
IT Consulting and Other Services
0.00
-
-
Vital Path, Inc.
Vital Path, Inc. develops content integration and migration, and business process management solutions. It offers PathBuilder, a platform that enables deployment of adapters that communicate with existing content repositories; and PathBuilder for Microsoft SharePoint, an enterprise application integration for content management platform that integrates repositories with SharePoint. The company also provides PathBuilder Migration Studio, a content migration solution that enables content owners to migrate repository structures; and ComplianceBuilder-Microsoft SharePoint Edition, an add-on compliance solution for Microsoft SharePoint. In addition, it offers ComplianceBuilder, a solution that monitors file-based systems for file changes; ComplianceBuilder Process Control, which collects data from an OPC server; compliance tools for enterprise databases; and ComplianceBuilder File Control, which monitors and collects Microsoft Office files into a repository. The company was founded in 1991 and is based in Bensalem, Pennsylvania. As of May 10, 2010, Vital Path, Inc. operates as a subsidiary of Xybion Medical Systems Corporation.

United States and Canada
Application Software
-
-
-
Xybion BC Finco Ltd.
Xybion BC Finco Ltd. was incorporated in 2021 and is based in Vancouver, Canada. Xybion BC Finco Ltd. operates as a subsidiary of Xybion Corporation.

United States and Canada
-
-
-
-
Xybion Technology Solutions, Inc.
Xybion Technology Solutions, Inc. is an IT consulting and services company. It provides computer system design and related services. The company is based in the United States.

United States and Canada
IT Consulting and Other Services
11.00
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Oct-3-2022
-
Public Offering
Target
Xybion Digital Inc. (TSXV:XYBN)


5.00
Dec-29-2021
-
Shelf Registration
Target
Xybion Digital Inc. (TSXV:XYBN)


39.28
May-26-2021
Nov-15-2021
Merger/Acquisition
Buyer
Gravitas One Capital Corp.
Xybion Corporation (nka:Xybion Digital Inc. (TSXV:XYBN))

9.02
May-10-2010
May-10-2010
Merger/Acquisition
Buyer
Vital Path, Inc. and Stelex-The Validation Group, Inc.
Xybion Digital Inc. (TSXV:XYBN)
Vital Signs, Inc.
-
Dec-1-2009
Dec-1-2009
Merger/Acquisition
Buyer
Amadeus International, Inc.
Xybion Digital Inc. (TSXV:XYBN)
Decimal Technologies, Inc.
-
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-14-2023
Client Announcements
Deciphex and Xybion Digital Inc. Join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows
Aug-08-2023
Strategic Alliances
Certara, Inc. and Xybion Digital Inc. Partner to Integrate Nonclinical R&D Software to Streamline Assessing Drug Safety & Efficacy
Jun-01-2023
Company Conference Presentations
Xybion Digital Inc. Presents at Healthcare IT Virtual Conference, Jun-01-2023
May-30-2023
Product-Related Announcements
Xybion to Streamline, Digitize and Optimize Stability Study Operations and Improve Compliance Using Labwise XD LIMS Platform
Mar-13-2023
Company Conference Presentations
Xybion Digital Inc. Presents at 35th Annual Roth Conference, Mar-12-2023 through Mar-14-2023

Competitors
Appian Corporation (NasdaqGM:APPN), Cority Software Inc., ETQ, LLC, Hyland Software, Inc., Intellex Co., Ltd. (TSE:8940), LabWare, Inc., MasterControl, Inc., MetricStream, Inc., Open Text Corporation (NasdaqGS:OTEX), ProcessMAP Corporation, Sparta Systems, Inc., STARLIMS Corporation, Veeva Systems Inc. (NYSE:VEEV)

M&A Advisors
Fasken Martineau DuMoulin LLP, Troutman Pepper Hamilton Sanders LLP


Advisors
Most Recent Auditor
Rotenberg Meril Solomon Bertiger & Guttilla, P.C.
M&A Advisors
Fasken Martineau DuMoulin LLP, Troutman Pepper Hamilton Sanders LLP


Most Recent Auditor
Rotenberg Meril Solomon Bertiger & Guttilla, P.C.


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
Wright Investors' Service Inc.

May 24, 2023 01:41 AM
XYBN
Flow of Funds Report for Xybion Digital Inc - prepared by Wright Investors Service
Notes
64
CFRA Equity Research

Nov 25, 2022 04:11 AM
XYBN
Xybion Digital Inc.
Reports
9


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


Banerjee M.B.A., Ph.D., Pradip K.

6,061,014

11.57

3.3

Nov-08-2022


McCoach, John 

1,563

0.00

0.0

Nov-08-2022


Bailey, Peter 

500

0.00

0.0

Nov-08-2022



 


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Products
ComplianceBuilder, CQRM XD, Design Consultation Services, Emidence XD, Implementation Services, Labwise XD, Maintenance Services, Pristima XD, Xybion Vital Path Suite


Recent Major Filings

Key Filings
Filed On
Company Name
Source
Form Type
Size
Oct-10-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
News Releases
217 KB
Sep-25-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
News Releases
172 KB
Sep-25-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
News Releases
172 KB
Sep-11-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
News Releases
217 KB
Aug-30-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
News Releases
216 KB
Aug-17-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
Statement of Executive Compensation
318 KB
Aug-14-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
News Releases
223 KB
Jul-28-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
Change of Auditor
554 KB
Jul-28-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
Change of Auditor
269 KB
Jul-28-2023
Xybion Digital Inc. (TSXV:XYBN)
SEDAR
Change of Auditor
271 KB

Key Board Members Details
Name
Title
Phone
Fax
Email
Banerjee, Pradip K.
Founder, CEO & Chairman of the Board
609 512 5790
609 482 3823
PBanerjee@xybion.com
McCoach, John 
Independent Director
(604) 562 6172
609 482 3823

Bailey, Peter 
Independent Lead Director
609 512 5790
609 482 3823

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Banerjee, Pradip K.
Founder, CEO & Chairman of the Board
609 512 5790
609 482 3823
PBanerjee@xybion.com
Biswas, Kamal 
President & COO
609 512 5790
609 482 3823

Porfano, Steven L.
CFO, Corporate Secretary & Executive VP
609 512 5790
609 482 3823

Abdallah, Mustafa 
Executive Director of Quality & Compliance Services
609 512 5790
609 482 3823

Friedman, Bob 
Chief Solution Architect
609 512 5790
609 482 3823

Krueger, Heidi 
Head of Quality Assurance
609 512 5790
609 482 3823

Rabenstein, Shawn 
Head of IT
609 512 5790
609 482 3823

Roy, Anu 
Chief Solutions Delivery Officer
609 512 5790
609 482 3823

* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
